Explore the full record of transactions filed by BNP PARIBAS DEVELOPPEMENT SOCIETE ANONYME, Shareholder. Director active across 1 companies, notably LNA SANTE. Aggregated, 1 reports have been recorded. Total volume traded: €707k. The latest transaction was disclosed on 13 May 2024 — Acquisition. Regulator: AMF. All data is openly available.
1 of 1 declaration
BNP Paribas Développement is the investment arm of the BNP Paribas group, dedicated to supporting high-performing SMEs, mid-cap companies and startups. As an autonomous subsidiary, it invests as a minority shareholder with a long-term capital philosophy, supporting management teams in growth, ownership transition and strategic development. In the case of LNA Santé, BNP Paribas Développement emerged as a key long-term financial partner, notably in the capital strengthening announced in early 2022. Its role fits into a broader strategy of supporting healthcare businesses, an area in which LNA Santé holds a recognized position in France and across Europe. The entity stands out for its expertise in minority investments, support for external growth and reinforcement of entrepreneurial continuity. It highlights a team of more than forty professionals and a regional presence across France, enabling it to combine local proximity with a long-term ownership mindset. Its approach aims to preserve company independence while giving businesses access to stable funding and strategic expertise. For LNA Santé, this is especially relevant because the group seeks to consolidate its development, strengthen its governance and support its ambitions in healthcare, dependency care and community-based services. Beyond pure financing, BNP Paribas Développement is known for its ability to support leaders over time, particularly through ownership transitions, organic growth and targeted acquisitions. In healthcare, this expertise is a strong advantage for a group such as LNA Santé, which must balance service quality, geographic expansion, financial discipline and management continuity. Its association with long-term investors and historical shareholders reinforces its role as a capital stabilizer and strategic partner.